These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22751537)

  • 21. Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.
    Lee JK; Yun KW; Choi EH; Kim SJ; Lee SY; Lee HJ
    J Korean Med Sci; 2017 Sep; 32(9):1431-1439. PubMed ID: 28776337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.
    Halasa NB; Grijalva CG; Arbogast PG; Talbot TR; Craig AS; Griffin MR; Schaffner W
    Pediatr Infect Dis J; 2013 Jun; 32(6):604-9. PubMed ID: 23348816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal Vaccination for French children.
    Mahjoub-Messai F; Doit C; Koeck JL; Billard T; Evrard B; Bidet P; Hubans C; Raymond J; Levy C; Cohen R; Bingen E
    J Clin Microbiol; 2009 Mar; 47(3):837-40. PubMed ID: 19109482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines.
    Laval CB; de Andrade AL; Pimenta FC; de Andrade JG; de Oliveira RM; Silva SA; de Lima EC; Fabio JL; Casagrande ST; Brandileone MC
    Clin Microbiol Infect; 2006 Jan; 12(1):50-5. PubMed ID: 16460546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine.
    Fenoll A; Aguilar L; Giménez MJ; Vicioso MD; Robledo O; Granizo JJ; Coronel P
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2696-8. PubMed ID: 20308373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R
    Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.
    Weil-Olivier C; van der Linden M; de Schutter I; Dagan R; Mantovani L
    BMC Infect Dis; 2012 Sep; 12():207. PubMed ID: 22954038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.
    Hampton LM; Farley MM; Schaffner W; Thomas A; Reingold A; Harrison LH; Lynfield R; Bennett NM; Petit S; Gershman K; Baumbach J; Beall B; Jorgensen J; Glennen A; Zell ER; Moore M
    J Infect Dis; 2012 Feb; 205(3):401-11. PubMed ID: 22158567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
    Kaur R; Casey JR; Pichichero ME
    Pediatr Infect Dis J; 2016 Aug; 35(8):901-6. PubMed ID: 27420806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska.
    Moore MR; Hyde TB; Hennessy TW; Parks DJ; Reasonover AL; Harker-Jones M; Gove J; Bruden DL; Rudolph K; Parkinson A; Butler JC; Schuchat A
    J Infect Dis; 2004 Dec; 190(11):2031-8. PubMed ID: 15529269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland.
    Hjálmarsdóttir MÁ; Quirk SJ; Haraldsson G; Erlendsdóttir H; Haraldsson Á; Kristinsson KG
    PLoS One; 2017; 12(1):e0169210. PubMed ID: 28125588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and microbiological characterization of serotype 6D pneumococcal infections in South Korea.
    Cheong HJ; Song JY; Choi MJ; Jeon JH; Kang SH; Jeong EJ; Noh JY; Kim WJ
    J Infect Chemother; 2016 Aug; 22(8):515-20. PubMed ID: 27234358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the Pneumococcal Conjugate Vaccine and Antibiotic Use on Nasopharyngeal Colonization by Antibiotic Nonsusceptible Streptococcus pneumoniae, Alaska, 2000[FIGURE DASH]2010.
    Gounder PP; Brewster M; Bruce MG; Bruden DJ; Rudolph K; Hurlburt DA; Hennessy TW
    Pediatr Infect Dis J; 2015 Nov; 34(11):1223-9. PubMed ID: 26226443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era.
    Hanage WP; Huang SS; Lipsitch M; Bishop CJ; Godoy D; Pelton SI; Goldstein R; Huot H; Finkelstein JA
    J Infect Dis; 2007 Feb; 195(3):347-52. PubMed ID: 17205472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.
    Gladstone RA; Jefferies JM; Tocheva AS; Beard KR; Garley D; Chong WW; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2015 Apr; 33(17):2015-21. PubMed ID: 25776920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.
    Tomczyk S; Lynfield R; Schaffner W; Reingold A; Miller L; Petit S; Holtzman C; Zansky SM; Thomas A; Baumbach J; Harrison LH; Farley MM; Beall B; McGee L; Gierke R; Pondo T; Kim L
    Clin Infect Dis; 2016 May; 62(9):1119-25. PubMed ID: 26908787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco.
    Diawara I; Barguigua A; Katfy K; Nayme K; Belabbes H; Timinouni M; Zerouali K; Elmdaghri N
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):23. PubMed ID: 28376809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.
    Pichichero ME; Casey JR
    Pediatr Infect Dis J; 2007 Oct; 26(10 Suppl):S12-6. PubMed ID: 18049375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.